Literature DB >> 8256198

Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis.

B R Brodeur1, D Martin, J Hamel, R D Shahin, C Laferrière.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8256198     DOI： 10.1007/bf00201101

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  46 in total

1.  Antigenic modulation of Bordetella pertussis.

Authors:  B W LACEY
Journal:  J Hyg (Lond)       Date:  1960-03

2.  The Phases of Haemophilus pertussis.

Authors:  P H Leslie; A D Gardner
Journal:  J Hyg (Lond)       Date:  1931-07

3.  The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection of mice.

Authors:  J P Ackers; J M Dolby
Journal:  J Gen Microbiol       Date:  1972-04

4.  Immunochemical studies on the lipopolysaccharides of Bordetella pertussis.

Authors:  M A Aprile; A C Wardlaw
Journal:  Can J Microbiol       Date:  1973-02       Impact factor: 2.419

5.  Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis.

Authors:  Z M Li; J L Cowell; M J Brennan; D L Burns; C R Manclark
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

6.  Taxonomic distribution of the antigen eliciting bactericidal antibody for Bordetella pertussis.

Authors:  J M Dolby; J P Ackers
Journal:  J Gen Microbiol       Date:  1975-04

7.  Selective primary health care: an interim strategy for disease control in developing countries.

Authors:  J A Walsh; K S Warren
Journal:  N Engl J Med       Date:  1979-11-01       Impact factor: 91.245

8.  Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide.

Authors:  R D Shahin; J Hamel; M F Leef; B R Brodeur
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

9.  Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels.

Authors:  L A Ashworth; R B Fitzgeorge; L I Irons; C P Morgan; A Robinson
Journal:  J Hyg (Lond)       Date:  1982-06

10.  Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis.

Authors:  J L Arciniega; E L Hewlett; F D Johnson; A Deforest; S G Wassilak; I M Onorato; C R Manclark; D L Burns
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226
View more
  5 in total

1.  Evaluation and validation of a monoclonal immunofluorescent reagent for direct detection of Bordetella pertussis.

Authors:  P McNicol; S M Giercke; M Gray; D Martin; B Brodeur; M S Peppler; T Williams; G Hammond
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

2.  Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes.

Authors:  L M Schaeffer; A A Weiss
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

3.  Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells.

Authors:  B M van den Berg; H Beekhuizen; F R Mooi; R van Furth
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

4.  Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide.

Authors:  R D Shahin; J Hamel; M F Leef; B R Brodeur
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

5.  Characterization of human bactericidal antibodies to Bordetella pertussis.

Authors:  A A Weiss; P S Mobberley; R C Fernandez; C M Mink
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.